Seaward Management Limited Partnership Lowers stake in MEDNAX Inc (MD)

MEDNAX Inc (MD) : Seaward Management Limited Partnership reduced its stake in MEDNAX Inc by 1.86% during the most recent quarter end. The investment management company now holds a total of 285,316 shares of MEDNAX Inc which is valued at $21,498,561 after selling 5,410 shares in MEDNAX Inc , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.MEDNAX Inc makes up approximately 1.14% of Seaward Management Limited Partnership’s portfolio.

Other Hedge Funds, Including , Strs Ohio reduced its stake in MD by selling 323 shares or 13.05% in the most recent quarter. The Hedge Fund company now holds 2,153 shares of MD which is valued at $162,229.Profit Investment Management reduced its stake in MD by selling 32,165 shares or 61.05% in the most recent quarter. The Hedge Fund company now holds 20,520 shares of MD which is valued at $1,557,673. MEDNAX Inc makes up approx 1.19% of Profit Investment Management’s portfolio. Denali Advisors sold out all of its stake in MD during the most recent quarter. The investment firm sold 16,300 shares of MD which is valued $1,220,544.Nn Investment Partners Holdings N.v. reduced its stake in MD by selling 175 shares or 0.54% in the most recent quarter. The Hedge Fund company now holds 32,310 shares of MD which is valued at $2,459,437. MEDNAX Inc makes up approx 0.02% of Nn Investment Partners Holdings N.v.’s portfolio.Gw&k Investment Management reduced its stake in MD by selling 63,025 shares or 19.7% in the most recent quarter. The Hedge Fund company now holds 256,864 shares of MD which is valued at $19,552,488. MEDNAX Inc makes up approx 0.40% of Gw&k Investment Management’s portfolio.

MEDNAX Inc closed down -1.02 points or -1.46% at $68.91 with 11,43,717 shares getting traded on Friday. Post opening the session at $69.31, the shares hit an intraday low of $68.18 and an intraday high of $69.84 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, MEDNAX Inc reported $1.03 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus of $1.07. The company had revenue of $771.80 million for the quarter, compared to analysts expectations of $774.46 million. The company’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 EPS.

Many Wall Street Analysts have commented on MEDNAX Inc. Company shares were Reiterated by Mizuho on Apr 29, 2016 to “Buy”, Firm has raised the Price Target to $ 79 from a previous price target of $75 .

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.

Leave a Reply

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.